¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2019-03-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2019-03-29
±³À°ÀÏÀÚ : 2019-03-29
±³À°Àå¼Ò : ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ 
±³À°ÁÖÁ¦ : ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ¿ì¿ï.Á¶¿ïº´ÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : Á¤Á¾Çö
¿¬¶ôó : 031-249-7150  
À̸ÞÀÏ : anton3@catholic.ac.kr      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 13 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï: Á¤È¸¿ø 5¸¸¿ø, ÁØȸ¿ø 3¸¸¿ø, ºñȸ¿ø 6¸¸¿ø, Æò»ýȸ¿ø ¸éÁ¦ ´çÀϵî·Ï: Á¤È¸¿ø 6¸¸¿ø, ÁØȸ¿ø 4¸¸¿ø, ºñȸ¿ø 8¸¸¿ø, Æò»ýȸ¿ø 1¸¸¿ø      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ09:10~09:35 Artificial or bright light  ±è°æ¹Î(±¹¸³³ªÁÖº´¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ09:35~10:00 Bibliotherapy  Àå¼¼Çå(ºÀ»ýº´¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ10:00~10:25 Calligraphy, drawing and hand writing  ±èÁö¼±(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ09:10~09:30 ½Å°æÀÎÁöÁúȯ¿¡¼­ ¹«°¨µ¿  ÀÌ°­¼ö(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ09:30~09:50 SSRI¿Í ¹«°¨µ¿  ¹ÚÁÖ¾ð(°è¿äº´¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ09:50~10:10 À½¼ºÁõ»ó°ú ¿ì¿ïÁõ»ó  °­½Â°É(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ10:10~10:25 ¹°Áú³²¿ë°ú ¹«°¨µ¿ÁõÈıº  À±È£°æ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ10:40~11:05 International and Korean prevalence and epidemiology of adult ADHD  È«Á¤¿Ï(Àͻ꺴¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ11:05~11:30 Young adulthood Persistence and comorbidities in Childhood-diagnosed ADHD in Hong Kong  Arthur D.P. Mak(Chinese Univ. of Hong Kong, Hong Kong) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ11:30~12:00 The Korean consensus for diagnosis and treatment of adult ADHD  ½É¼¼ÈÆ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ10:40~11:05 Introduction: Resilience  ÀÓÀº¼º(½Å¼¼°èÈ¿º´¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ11:05~11:30 Resilience in depression and bipolar disorder  ¼®Á¤È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ11:30~12:00 How to enhance resilience  ÀÌ°­¿í(°­¿øÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ12:00~12:30 Does ¡°Remission¡± is really the only matter?: Focus on negative & positive affects of depression  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ12:30~13:00 Efficacy and safety of Agomelatine: Comparison with other antidepressants  ³²¹ü¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ12:00~12:30 What are better treatment options for bipolar disorder?  ¹Ú¿µ¹Î(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ12:30~13:00 How to optimize pharmacological treatment?  ¼­Á¤¼®(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ13:30~13:55 Á¤½Å°Ç°­º¹Áö¹ý°ú ÀÇ·áÇöÀå¿¡¼­ÀÇ Æø·Â  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ13:55~14:20 Prevalence and Korean situation  ¿ÀÈ«¼®(°Ç¾çÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ14:20~14:50 Management of violence in clinical setting  Á¤Á¾Çö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ13:30~13:50 È¥À缺 ¾ç»óÀÇ °³³ä°ú º¯Ãµ  ½ÉÀÎÈñ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ13:50~14:10 È¥À缺 ¿ì¿ïÀÇ ¹ß°ß°ú Ä¡·á  ÀüÈ«Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ14:10~14:30 È¥À缺 (°æ)Á¶ÁõÀÇ Ä¡·á  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ14:30~14:50 ÀÜ·ù Áõ»óÀÇ Á߿伺°ú Ä¡·á  ±è¿ø(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ14:50~15:50 The use of SNRI as the 1st treatment of MDD  ¼ºÇü¸ð(Â÷ÀÇ°úÇдë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ14:50~15:10 EEG and mood disorder  Á¤¸íÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ15:10~15:30 Vitamin D, omega 3 fatty acids and mood disorder  ¿Õ¼º¹Î(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ15:30~15:50 Gut microbiota and mood disorder  ¼ÛÈĸ²(¸íÁöº´¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ16:00~17:00 PythonÀ¸·Î ÇÒ ¼ö ÀÖ´Â ¸ðµç °Í  ÀÌÁø¼®(Ask Company) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ16:00~16:20 Emotional regulation in bipolar disorder  ¼Û¹Î±Ô(¼º¸ð°ø°¨Á¤½Å°Ç°­ÀÇÇаúÀÇ¿ø) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ16:20~16:40 Self-injury, a sign of suicide ?  ±è½Â°ï(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 29ÀÏ ¼­¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ ¹× ´ëȸÀǽǠ16:40~17:00 Suicide of medical staff  °­ÇÑ°íÀººñ(±¹¸³³ªÁÖº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ¿ì¿ïÁ¶¿ïº´ÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2019-03-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÀÚ±â°ø¸íÀÇ°úÇÐȸ ICMRI 2019 : 2019-03-29
´ÙÀ½±Û 2019³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ Ãá°èÁý´ãȸ : 2019-03-29
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 45 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 35 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 37 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 46 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 38 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 30 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 12 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 12 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 28 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 14 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 12 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 32 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 23 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 27 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 22 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷